Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)
CNY 19.25
(-3.12%)
CNY 19.25
(-3.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.9 Billion | 1.51 Billion | 1.35 Billion | 1.16 Billion | 1.3 Billion | 983.77 Million |
| Cost of Revenue | 899.83 Million | 638.58 Million | 545.09 Million | 443.65 Million | 496.78 Million | 379.95 Million |
| Gross Profit | 1 Billion | 876.46 Million | 808.69 Million | 718.05 Million | 809.13 Million | 603.81 Million |
| Operating Expenses | 860.45 Million | 752.99 Million | 723.13 Million | 564.11 Million | 650.74 Million | 477.69 Million |
| Selling, General and Administrative Expenses | 756.42 Million | 599.55 Million | 568.81 Million | 501.24 Million | 574.1 Million | 402.7 Million |
| Research and Development Expenses | 93.91 Million | 105.66 Million | 100.43 Million | 51.66 Million | 51.66 Million | 43.33 Million |
| Other Expenses | 10.11 Million | 47.78 Million | 53.88 Million | 11.2 Million | 24.98 Million | 1.9 Million |
| Cost and Expenses | 1.76 Billion | 1.39 Billion | 1.26 Billion | 1 Billion | 1.14 Billion | 857.65 Million |
| Operating Income | 136.93 Million | 96.62 Million | 100.3 Million | 134.17 Million | 141.55 Million | 116.57 Million |
| Interest Expense | 18.55 Million | 17.99 Million | 13.86 Million | 9.1 Million | 13.36 Million | 8.9 Million |
| Income Tax Expense | 22.87 Million | 12.48 Million | 12.1 Million | 12.88 Million | 21.91 Million | 17.93 Million |
| Earnings before Tax | 135.49 Million | 97.22 Million | 81.66 Million | 134.38 Million | 142.24 Million | 118.47 Million |
| Net Income | 106.49 Million | 85.68 Million | 72.13 Million | 121.5 Million | 120.32 Million | 100.53 Million |
| Earnings Per Share Basic | 0.27 | 0.21 | 0.18 | 0.30 | 0.30 | 0.31 |
| Earnings Per Share Diluted | 0.27 | 0.21 | 0.18 | 0.30 | 0.30 | 0.31 |
| Weighted Average Shares Outstanding | 394.43 Million | 400.1 Million | 400.1 Million | 400.1 Million | 400.1 Million | 324.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 394.43 Million | 400.1 Million | 400.1 Million | 400.1 Million | 400.1 Million | 324.31 Million |
| Gross Margin | 0.53 | 0.58 | 0.60 | 0.62 | 0.62 | 0.61 |
| EBIT Margin | 0.11 | 0.11 | 0.11 | 0.17 | 0.16 | 0.17 |
| Profit Margin | 0.06 | 0.06 | 0.05 | 0.10 | 0.09 | 0.10 |
| EBITDA | 213.41 Million | 167.67 Million | 148.17 Million | 189.46 Million | 198.5 Million | 163.23 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.07 | 0.12 | 0.11 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 343.66 Million | 412 Million | 430.4 Million | 627.2 Million | 1.9 Billion | 363.99 Million |
| Cost of Revenue | 123.01 Million | 200.95 Million | 224.81 Million | 280.89 Million | 899.83 Million | 182.28 Million |
| Gross Profit | 220.64 Million | 211.05 Million | 205.58 Million | 346.31 Million | 1 Billion | 181.7 Million |
| Operating Expenses | 217.09 Million | 178.48 Million | 165.9 Million | 288.21 Million | 814.93 Million | 154.96 Million |
| Selling, General and Administrative Expenses | 199.07 Million | 156.7 Million | 149.74 Million | 177.18 Million | - | 168.79 Million |
| Research and Development Expenses | 17.84 Million | 19.04 Million | 19.33 Million | 43.58 Million | - | 20.25 Million |
| Other Expenses | -179.71 Thousand | -2.73 Million | 559.65 Thousand | -672.01 Thousand | -1.44 Million | -116.08 Thousand |
| Cost and Expenses | 340.11 Million | 379.44 Million | 390.72 Million | 569.1 Million | 1.71 Billion | 337.24 Million |
| Operating Income | 3.55 Million | 32.56 Million | 35.64 Million | 33.35 Million | 136.93 Million | 16.61 Million |
| Interest Expense | 8.76 Million | 6.93 Million | 5.88 Million | 2.8 Million | 18.23 Million | 7.33 Million |
| Income Tax Expense | -6.24 Million | 7.34 Million | 6.04 Million | 2.87 Million | 22.87 Million | -3.12 Million |
| Earnings before Tax | 1.3 Million | 59.55 Million | 36.2 Million | 32.68 Million | 135.49 Million | 16.5 Million |
| Net Income | 5.13 Million | 49.71 Million | 29.03 Million | 28.99 Million | 106.49 Million | 16.13 Million |
| Earnings Per Share Basic | 0.01 | 0.12 | 0.07 | 0.08 | - | 0.04 |
| Earnings Per Share Diluted | 0.01 | 0.12 | 0.07 | 0.08 | - | 0.04 |
| Weighted Average Shares Outstanding | 400.1 Million | 400.1 Million | 414.74 Million | 354.02 Million | 394.43 Million | 400.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 400.1 Million | 400.1 Million | 414.74 Million | 354.02 Million | 394.43 Million | 400.1 Million |
| Gross Margin | 0.64 | 0.51 | 0.48 | 0.55 | 0.53 | 0.50 |
| EBIT Margin | 0.03 | 0.11 | 0.10 | 0.09 | - | 0.07 |
| Profit Margin | 0.01 | 0.12 | 0.07 | 0.05 | 0.06 | 0.04 |
| EBITDA | 10.06 Million | 46.77 Million | 43.16 Million | 57.69 Million | - | 26.06 Million |
| Earnings Before Tax Margin | 0.01 | 0.08 | 0.08 | 0.05 | 0.07 | 0.05 |
141080
HTZWW
034300
DEF
603600
DZRD